Oldinot Duo

Combination of a selective and reversible acetylcholinesterase inhibitor and an antagonist of N-methyl-d-aspartate receptors (NMDA). Indicated to the treatment of moderate to severe Alzheimer-type dementia.

Therapeutic Area
Alzheimer

Active Ingredient
Donepezil + Memantine

Line
Neurosciences

Pharmaceutical Forms
10 mg controlled-release tablets x 30
28 mg controlled-release tablet x 30

Download Leaflet Descargar